"Die Augentagesklinik Rheine gehört seit Kurzem zu den Precise Vision Augenärzten. Dr. med. Florian Kretz (FEBO) bleibt dem Standort als Ärztlicher Direktor und geschäftsführender Gesellschafter erhalten. Es wird ein neues Logo und verbesserten Service mit kürzeren Wartezeiten geben. Spezialisiert sind wir vor allem auf Grauer Star OPs mit besonders schonenden und sicheren Methoden sowie refraktive Chirurgie. Gleichzeitig sind Dr. Kretz und sein Team aber auch kompetente Ansprechpartner bei AMD, Glaukomen, Lidchirurgie, trockenen Augen sowie vielen weiteren operativen und konservativen Behandlungen. Wenn Sie Fragen haben oder sich über bestimmte Behandlungsmöglichkeiten informieren möchten, erreichen Sie uns telefonisch unter 0800 3 100 900"

During the past decade, Augentagesklinik Rheine conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Augentagesklinik Rheine" #1 collaborator was "targomedGmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Augentagesklinik Rheine" are "Cataract" (3 trials), "Lens Opacities" (2 trials), "Aphakia, Postcataract" (1 trials), "Cataract; Eye Disease" (1 trials) and "Neovascular Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Augentagesklinik Rheine" in a lesser frequency.

Most popular intervention types in "Augentagesklinik Rheine" are "Device" (4 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AKST4290" (1 trials), "AT LARA IOL" (1 trials), "AT LISA Tri IOL" (1 trials), "AcrySof® IOL" (1 trials) and "Aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Augentagesklinik Rheine" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Augentagesklinik Rheine". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Augentagesklinik Rheine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Augentagesklinik Rheine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".